• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • Login
  • 0Shopping Cart

  • COVID-19 Resources
  • Knowledge Center
  • Blog
  • Featured
    • View Webinars On-Demand
    • The In Vitro Diagnostics Market: $83 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • Free Downloads
  • About Us
  • Research Index
  • Contact
  • Search
  • Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology
  • Diagnostics
  • Healthcare
  • Medical Devices
  • Pharmaceuticals

Knowledge Center Sidebar

Most Popular Research

  • The Worldwide Market for In Vitro Diagnostics, 13th Edition
  • Clinical Diagnostics MasterFile
  • Benchmarking for 2021: Understanding the Clinical Diagnostics Customer Experience
  • Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets
  • Clinical Laboratory Services Market, 5th Edition
    $4,750.00 – $9,500.00
    Clinical laboratories are an essential part of the health industry. The market for laboratory services ranges from routine blood work to esoteric laboratory-developed tests (LDTs). In addition to diagnosing patients, clinical lab testing may be performed to evaluate disease progression, to monitor drug treatment and conditions, and to determine individual therapy. Kalorama’s Clinical Laboratory Services […]
    January 27, 2020
  • NASH Drug Pipeline and Market Overview
    $2,000.00 – $4,000.00
    Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD). NASH is characterized by inflammation in the liver and liver cell damage, which can lead to scarring of the liver (cirrhosis). No medications have been approved specifically for NASH but there are numerous products in development. NASH Drug Pipeline and Market Overview looks […]
    January 6, 2020
  • CAR-T Cell Therapy Market Review
    $4,000.00 – $8,000.00
    CAR-T cell therapy is a form of immunotherapy that utilizes the body’s own T cells to target and destroy cancer cells. This therapy is a personalized form of treatment, meaning that each patient receives T cells that are geared specifically toward his or her cancer diagnosis. T-cell therapy works by removing existing T cells from […]
    December 19, 2019
  • Exome Sequencing Market
    $4,000.00 – $8,000.00
    The increasing popularity of next-generation systems has fueled systems and sequencers, but the cost of sequencing – despite price declines – has led to demands for more efficient methods. Exome Sequencing is a widely used NGS technique that sequences all the exons in a genome. Rather than sequencing the entire human genome, only pieces of […]
    November 25, 2019
  • Blockchain Technologies in Healthcare
    $2,000.00 – $4,000.00
    Blockchain is essentially a tool that has the potential to keep secure data in a distributed ledger with the capability to be shared across networks. The concept behind blockchain is that it has three components: a widely distributed network a shared ledger with validated access identities digital transactions Blockchain technology is emerging in many other […]
    November 22, 2019
  • Current IVD Market Trends
    $3,000.00 – $6,000.00
    This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture. The topics discussed are the following: The Worldwide IVD Market, 2019-2024 Market Developments in Selected Markets – North America, EU15/Western Europe, Eastern Europe, Japan and China Genetic Testing […]
    October 31, 2019
  • The Global Market for Medical Devices, 10th Edition (45 Specific Device Markets and 50 Country Markets Forecasted to 2024)
    $4,000.00 – $8,000.00
    The Global Market for Medical Devices, 10th edition, provides a comprehensive view of the medical device market and opportunity for medical device manufacturers, competitors, and investors. The report examines the companies in the market, the types of devices sold across the global market, and the country markets they are sold in. As part of its […]
    October 28, 2019
  • The World Market for HbA1c Tests
    $5,000.00 – $10,000.00
    Given its effectiveness in detecting and monitoring treatment of diabetes, HbA1c has become a high-growth and highly competitive market in IVD testing. Globally, a growing amount of dollars is being spent annually on HbA1c testing, for both professional and self-testing. Over a dozen companies produce analyzers, reagents, workstations, and point-of-care (POC) devices that run HbA1c […]
    October 17, 2019
  • IVD Test Procedure Volumes, 2019-2024
    $5,000.00 – $10,000.00
    In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2019-2024 saves time with calculations and estimates of the both the existing number of procedures for […]
    October 11, 2019
  • The Market for Artificial Intelligence (AI) in Healthcare
    $5,000.00 – $10,000.00
    Issues facing the healthcare industry are challenging and complex, including staff reductions, increased service demands and funding cuts. It is not surprising then that many are looking to the advanced solutions that artificial intelligence (AI) can offer in this realm. Kalorama Information’s report, The Market for Artificial Intelligence (AI) in Healthcare, quantifies the opportunity and […]
    September 27, 2019
Page 4 of 77«‹23456›»

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • COVID-19 Diagnostics Market Blog: FDA Tightens on Variants, Thermo Launches 8,000 Sample/Day COVID-19 Test; Quest Tasked by CDC to Identify COVID-19 Mutations; COVID-19 One Year Later, Ellume Home Test, Visby and More February 24, 2021
  • Molecular Point of Care Test Market Nearly Triples in One Year, Due to COVID-19. January 26, 2021
  • COVID-19 Pandemic Accelerates Adoption of Diagnostic Testing at Point of Care January 12, 2021
  • Science and Medicine Groups Predictions for 2021 in the Lab Instrumentation, Diagnostics and Imaging Industries January 7, 2021
  • For Roche, Alignment Between Tests and COVID-19 Vaccines is Key December 14, 2020

Sitemap

  • Home
  • About
  • Blog
  • Contact

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Scroll to top
Register for Access Login for Access

Register for Access Login for Access

Lost your password? Register